Last updated: 22 July 2019 at 2:39pm EST

Jeanalta Partnersalta Calif... Net Worth




The estimated Net Worth of Jeanalta Partnersalta Calif... is at least $10.1 Million dollars as of 7 May 2004. Jeanalta Calif owns over 3,100 units of Rigel Pharmaceuticals stock worth over $104,409 and over the last 21 years Jeanalta sold RIGL stock worth over $9,954,025.

Jeanalta Calif RIGL stock SEC Form 4 insiders trading

Jeanalta has made over 12 trades of the Rigel Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently Jeanalta sold 3,100 units of RIGL stock worth $66,650 on 7 May 2004.

The largest trade Jeanalta's ever made was selling 111,696 units of Rigel Pharmaceuticals stock on 19 February 2004 worth over $2,233,920. On average, Jeanalta trades about 37,106 units every 6 days since 2004. As of 7 May 2004 Jeanalta still owns at least 8,050 units of Rigel Pharmaceuticals stock.

You can see the complete history of Jeanalta Calif stock trades at the bottom of the page.



Insiders trading at Rigel Pharmaceuticals

Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke, and Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.



What does Rigel Pharmaceuticals do?

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.



What does Rigel Pharmaceuticals's logo look like?

Rigel Pharmaceuticals logo

Complete history of Jeanalta Calif stock trades at Rigel Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
7 May 2004 Jeanalta Partnersalta Calif...
Sale 3,100 $21.50 $66,650
7 May 2004
8,050
3 May 2004 Jeanalta Partnersalta Calif...
Sale 95,200 $21.31 $2,028,712
3 May 2004
8,119
30 Apr 2004 Jeanalta Partnersalta Calif...
Sale 8,400 $21.25 $178,500
30 Apr 2004
10,245
28 Apr 2004 Jeanalta Partnersalta Calif...
Sale 42,800 $21.25 $909,500
28 Apr 2004
10,433
26 Apr 2004 Jeanalta Partnersalta Calif...
Sale 8,900 $21.26 $189,214
26 Apr 2004
11,389
23 Apr 2004 Jeanalta Partnersalta Calif...
Sale 13,100 $21.32 $279,292
23 Apr 2004
11,588
21 Apr 2004 Jeanalta Partnersalta Calif...
Sale 8,800 $21.26 $187,088
21 Apr 2004
11,881
8 Apr 2004 Jeanalta Partnersalta Calif...
Sale 60,300 $21.00 $1,266,300
8 Apr 2004
12,077
5 Apr 2004 Jeanalta Partnersalta Calif...
Sale 10,900 $21.21 $231,189
5 Apr 2004
13,424
24 Mar 2004 Jeanalta Partnersalta Calif...
Sale 7,487 $20.00 $149,740
24 Mar 2004
13,668
19 Feb 2004 Jeanalta Partnersalta Calif...
Sale 111,696 $20.00 $2,233,920
19 Feb 2004
13,003
19 Feb 2004 Jeanalta Partnersalta Calif...
Sale 111,696 $20.00 $2,233,920
19 Feb 2004
13,003


Rigel Pharmaceuticals executives and stock owners

Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: